Two Sigma Advisers’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Sell |
551,700
-24,700
| -4% | -$81.8K | ﹤0.01% | 1164 |
|
|
2025
Q1 | $1.67M | Buy |
576,400
+560,400
| +3,503% | +$1.63M | ﹤0.01% | 1234 |
|
|
2024
Q4 | $57K | Buy |
+16,000
| New | +$57K | ﹤0.01% | 2272 |
|
|
2024
Q3 | – | Sell |
-24,200
| Closed | -$62.9K | – | 2277 |
|
|
2024
Q2 | $62.9K | Buy |
24,200
+9,400
| +64% | +$24.4K | ﹤0.01% | 2348 |
|
|
2024
Q1 | $63K | Sell |
14,800
-12,000
| -45% | -$51.1K | ﹤0.01% | 2336 |
|
|
2023
Q4 | $54.1K | Sell |
26,800
-3,300
| -11% | -$6.67K | ﹤0.01% | 2395 |
|
|
2023
Q3 | $46.1K | Buy |
30,100
+1,700
| +6% | +$2.6K | ﹤0.01% | 2283 |
|
|
2023
Q2 | $46.9K | Buy |
28,400
+5,300
| +23% | +$8.75K | ﹤0.01% | 2280 |
|
|
2023
Q1 | $26.3K | Sell |
23,100
-9,300
| -29% | -$10.6K | ﹤0.01% | 2502 |
|
|
2022
Q4 | $29.2K | Sell |
32,400
-7,500
| -19% | -$6.77K | ﹤0.01% | 2404 |
|
|
2022
Q3 | $47K | Sell |
39,900
-8,000
| -17% | -$9.42K | ﹤0.01% | 2377 |
|
|
2022
Q2 | $31K | Sell |
47,900
-4,500
| -9% | -$2.91K | ﹤0.01% | 2516 |
|
|
2022
Q1 | $137K | Sell |
52,400
-9,400
| -15% | -$24.6K | ﹤0.01% | 2447 |
|
|
2021
Q4 | $240K | Buy |
61,800
+14,500
| +31% | +$56.3K | ﹤0.01% | 2221 |
|
|
2021
Q3 | $206K | Buy |
47,300
+10,900
| +30% | +$47.5K | ﹤0.01% | 2240 |
|
|
2021
Q2 | $145K | Buy |
36,400
+25,200
| +225% | +$100K | ﹤0.01% | 2310 |
|
|
2021
Q1 | $58K | Buy |
+11,200
| New | +$58K | ﹤0.01% | 2493 |
|
|
2020
Q4 | – | Sell |
-17,500
| Closed | -$85K | – | 2379 |
|
|
2020
Q3 | $85K | Sell |
17,500
-6,300
| -26% | -$30.6K | ﹤0.01% | 2283 |
|
|
2020
Q2 | $116K | Buy |
23,800
+6,500
| +38% | +$31.7K | ﹤0.01% | 2342 |
|
|
2020
Q1 | $38K | Buy |
17,300
+6,300
| +57% | +$13.8K | ﹤0.01% | 2390 |
|
|
2019
Q4 | $64K | Buy |
+11,000
| New | +$64K | ﹤0.01% | 2280 |
|